C WorldWide Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $431K | Hold |
100,000
| – | – | 0.01% | 93 |
|
2025
Q1 | $374K | Hold |
100,000
| – | – | ﹤0.01% | 92 |
|
2024
Q4 | $1.01M | Hold |
100,000
| – | – | 0.01% | 84 |
|
2024
Q3 | $1.25M | Hold |
100,000
| – | – | 0.01% | 83 |
|
2024
Q2 | $1.3M | Hold |
100,000
| – | – | 0.01% | 84 |
|
2024
Q1 | $2.27M | Hold |
100,000
| – | – | 0.03% | 71 |
|
2023
Q4 | $1.3M | Hold |
100,000
| – | – | 0.02% | 80 |
|
2023
Q3 | $2.01M | Hold |
100,000
| – | – | 0.03% | 74 |
|
2023
Q2 | $2.69M | Hold |
100,000
| – | – | 0.03% | 71 |
|
2023
Q1 | $5.84M | Hold |
100,000
| – | – | 0.08% | 66 |
|
2022
Q4 | $5.1M | Hold |
100,000
| – | – | 0.07% | 57 |
|
2022
Q3 | $8.19M | Hold |
100,000
| – | – | 0.11% | 48 |
|
2022
Q2 | $6.77M | Hold |
100,000
| – | – | 0.08% | 52 |
|
2022
Q1 | $11.1M | Hold |
100,000
| – | – | 0.12% | 45 |
|
2021
Q4 | $9.65M | Buy |
100,000
+20,000
| +25% | +$1.93M | 0.09% | 49 |
|
2021
Q3 | $6.98M | Hold |
80,000
| – | – | 0.07% | 57 |
|
2021
Q2 | $12.4M | Hold |
80,000
| – | – | 0.13% | 46 |
|
2021
Q1 | $12.6M | Buy |
80,000
+40,000
| +100% | +$6.31M | 0.12% | 51 |
|
2020
Q4 | $9.29M | Buy |
+40,000
| New | +$9.29M | 0.09% | 56 |
|
2018
Q4 | – | Sell |
-1,217
| Closed | -$311K | – | 128 |
|
2018
Q3 | $311K | Buy |
1,217
+176
| +17% | +$45K | ﹤0.01% | 121 |
|
2018
Q2 | $265K | Hold |
1,041
| – | – | ﹤0.01% | 119 |
|
2018
Q1 | $210K | Sell |
1,041
-29
| -3% | -$5.85K | ﹤0.01% | 118 |
|
2017
Q4 | $154K | Sell |
1,070
-164
| -13% | -$23.6K | ﹤0.01% | 120 |
|
2017
Q3 | $203K | Buy |
1,234
+189
| +18% | +$31.1K | ﹤0.01% | 122 |
|
2017
Q2 | $142K | Sell |
1,045
-84
| -7% | -$11.4K | ﹤0.01% | 126 |
|
2017
Q1 | $217K | Buy |
1,129
+262
| +30% | +$50.4K | ﹤0.01% | 119 |
|
2016
Q4 | $122K | Buy |
+867
| New | +$122K | ﹤0.01% | 123 |
|